Fifth Medical Center, Chinese PLA General Hospital, Beijing, China. National Cancer Center Hospital, Tokyo, Japan. Centre Hospitalier Paris Saint-Joseph, Paris, France. Department of Medical Oncology, The Christie NHS Foundation Trust/Division of Cancer Sciences, University of Manchester, Manchester, UK. The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. Anhui Provincial Hospital, Hefei, China. Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea. The First Affiliated Hospital of Xinxiang Medical College, Xinxiang, China. Cancer Hospital of Shantou University Medical College, Shantou, China. Liaoning Cancer Hospital, Shenyang, China. Wuxi Fourth People's Hospital, Wuxi, China. The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China. Beijing Cancer Hospital, Beijing, China. National Cancer Center Hospital East, Chiba, Japan. Ivanovo Regional Oncology Dispensary, Ivanovo, Russia. Osaka International Cancer Institute, Osaka, Japan. Maria Sklodowska-Curie National Cancer Research Institute, Warsaw, Poland. University Hospitals Gasthuisberg, Leuven, and KU Leuven, Leuven, Belgium. Central University Hospital of Asturias, ISPA, Oviedo, Spain. China Medical University Hospital and China Medical University, Taichung, Taiwan. Clinical Development, BeiGene (Beijing), Beijing, China. Clinical Biomarker, BeiGene (Beijing), Beijing, China. Department of Oncology, Mayo Clinic, Rochester, MN, USA. Electronic address: yoon.harry@mayo.edu.